WUKOMNI Trademark

Trademark Overview


On Tuesday, June 7, 2022, a trademark application was filed for WUKOMNI with the United States Patent and Trademark Office. The USPTO has given the WUKOMNI trademark a serial number of 97447038. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 12, 2023. This trademark is owned by Dizal (Jiangsu) Pharmaceutical Co., Ltd.. The WUKOMNI trademark is filed in the Pharmaceutical Products category with the following description:

Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronch...
wukomni

General Information


Serial Number97447038
Word MarkWUKOMNI
Filing DateTuesday, June 7, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Description of MarkThe mark consists of the literal element "WUKOMNI" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Goods and ServicesAcids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording WUKOMNI has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDizal (Jiangsu) Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWuxi City, Jiangsu, .
CN

Party NameDizal (Jiangsu) Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWuxi City, Jiangsu, .
CN

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 22, 2023ASSIGNED TO EXAMINER
Friday, June 17, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 10, 2022NEW APPLICATION ENTERED